Steven H Holtzman's Net Worth
$14 Million
Who is Steven H Holtzman?
Steven H Holtzman has an estimated net worth of $14 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., INFINITY PHARMACEUTICALS, INC., and ANADYS PHARMACEUTICALS INC.
SEC CIK
Steven H Holtzman's CIK is 0001300247
Past Insider Trading and Trends
2006 was Steven H Holtzman's most active year for acquiring shares with 7 total transactions. Steven H Holtzman's most active month to acquire stocks was the month of January. 2014 was Steven H Holtzman's most active year for disposing of shares, totalling 14 transactions. Steven H Holtzman's most active month to dispose stocks was the month of January. 2008 saw Steven H Holtzman paying a total of $508,190.20 for 318,999 shares, this is the most they've acquired in one year. In 2012 Steven H Holtzman cashed out on 279,651 shares for a total of $3,553,466.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
EVP Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.82% | 306 |
$258.99 | -$70,704.27 | 8.33K |
Feb 23
| |||
Form 4
| +30.62% | 1.88K |
$247.22 | -$324,847.08 | 8.02K |
Feb 12
| |||
Form 4
| +42.10% | 1.82K |
$250.77 | -$223,185.30 | 6.14K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| -33.00% | -2.13K |
$389.11 | -$828,026.08 | 4.32K |
Scheduled
|
Feb 17
| ||
Form 4
| +42.46% | 1.92K |
$392.11 | -$671,292.32 | 6.45K |
Feb 12
| |||
Form 4
| +46.17% | 1.43K |
$402.00 | -$512,550.00 | 4.53K |
Feb 8
| |||
Form 4
|
∞
| 3.1K |
$389.16 | -$801,669.60 | 3.1K |
Feb 1
| |||
Form 4
| -100.00% | -1.75K |
$335.65 | -$587,051.85 |
0
|
Scheduled
|
Dec 2
| ||
Form 4
| -50.01% | -1.75K |
$330.00 | -$577,500.00 | 1.75K |
Scheduled
|
Nov 11
| ||
Form 4
| -33.34% | -1.75K |
$330.97 | -$579,197.50 | 3.5K |
Scheduled
|
Oct 1
| ||
Form 4
| -8.70% | -500.00 |
—
|
—
| 5.25K |
Sep 18
| |||
Form 4
| -17.52% | -1.22K |
$289.15 | -$353,052.15 | 5.75K |
Scheduled
|
May 19
| ||
Form 4
| -14.91% | -1.22K |
$291.00 | -$355,311.00 | 6.97K |
Scheduled
|
Apr 17
| ||
Form 4
| -12.97% | -1.22K |
$334.83 | -$408,827.43 | 8.19K |
Scheduled
|
Mar 17
| ||
Form 4
| -11.49% | -1.22K |
$327.90 | -$400,693.80 | 9.41K |
Scheduled
|
Feb 18
| ||
Form 4
| +11.91% | 1.13K |
$323.04 | -$326,270.40 | 10.63K |
Feb 12
| |||
Form 4
| +17.70% | 1.43K |
$315.54 | -$402,629.04 | 9.5K |
Feb 8
| |||
Form 4
| +65.26% | 3.19K |
$312.64 | -$616,213.44 | 8.07K |
Feb 1
| |||
Form 4
| -41.75% | -3.50K |
$238.98 | -$836,668.98 | 4.88K |
Scheduled
|
Sep 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +20.11% | 1.4K |
$164.44 | -$154,573.60 | 8.39K |
Feb 8
| |||
Form 4
| +99.43% | 3.48K |
$157.30 | -$263,949.40 | 6.98K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 3.5K |
$121.26 | -$201,049.08 | 3.5K |
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
Exec Chair the Board of Dir
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -57.57K |
$13.01 | -$749,024.73 |
0
|
May 31
| |||
Form 4
| -78.90% | -215.26K |
$13.00 | -$2,603,393.00 | 57.57K |
May 18 - May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +56.97% | 100K |
—
|
—
| 275.54K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4/A
| +10.61% | 33.15K |
$3.48 | $115,375.92 | 345.67K |
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 4
| +14.20% | 88.74K |
$2.76 | $229,252.08 | 713.77K |
Oct 27
| |||
Form 4
| +9.41% | 22.1K |
$7.40 | $163,562.20 | 256.93K |
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
| +2.18% | 5K |
$9.12 | $45,600.50 | 234.82K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
∞
| 407.18K |
—
|
—
| 407.18K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANADYS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Camp4 Therapeutics Corp (CAMP) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.91% | 8.92K |
—
|
—
| 108.95K |
Oct 15
| |||
| No matching records found | |||||||||